Clinical Trial Update: Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） [Phase 2]

View source ↗

Summary

Phase 2 trial update on disitamab vedotin combined with PD-1 and neoadjuvant chemotherapy for locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)
• PD-1

Snippet

Sponsor: Guoxin Li | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN